Toxicities of CMV Preemptive Therapy in the First 100 Days After Allogeneic Hematopoietic Cell Transplantation (HCT): A Real-World Study at Memorial Sloan Kettering Cancer Center (MSKCC)
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.601
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Elsevier BV